Donepezil in the Prevention of Post-Operative Cognitive Decline

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-02-28

Study Completion Date

2007-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the feasibility of using Donepezil to prevent post-operative cognitive decline (POCD) among individuals aged 65 and older who have a baseline mild cognitive impairment (MCI) and are undergoing elective hip or knee replacement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevention of Postoperative Delirium With Donepezil

NCT00220896

Cognitively Normal Elderly Individuals

COMPLETED PHASE4

Donepezil in Preventing Delirium in Hospitalized Elderly

NCT00182884

Postoperative Complications Delirium

COMPLETED PHASE4

Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period

NCT00586196

Delirium

COMPLETED PHASE2

Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction

NCT04423276

Total Knee Arthroplasty Fracture of Head of Femur Articular Displaced Protrusion of Intervertebral Disc

UNKNOWN PHASE4

Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery

NCT04267328

Post Operative Cognitive Dysfunction

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Up to 65% of elderly patients undergoing hip or knee surgery suffer from declining brain function known as post-operative cognitive decline (POCD). These individuals often stay in the hospital longer, have more complications, and are more likely to die. Recent clinical studies have shown the potential benefit of enhancing the cholinergic system among patients with both Alzheimer's disease and / or vascular dementia. Donepezil is currently being used to treat memory loss in patients with Alzheimer's disease.

This study will recruit 30 cognitively impaired adults aged 65 or older who are scheduled to have elective hip or knee replacement surgery at University Hospital. Participants will be randomized to receive either a three to six week supply of Donepezil or a matching placebo approximately 4 weeks prior to surgery. This study will evaluate the effect of Donepezil on delirium incidence and severity during hospitalization, global cognitive function, length of hospitalization, site of discharge, and adverse drug effects.

All material to be collected will be from interviews, questionnaires, and medical chart review. Some will be at baseline, during hospitalization, and 12 weeks post hospitalization and others will be daily during hospitalization. The International Study of Post-Operative Cognitive Decline battery of tests will be used in assessment, as will the CogHealth computerized battery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Complications Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Donepezil

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Community-dwelling individuals aged 65 or older
* Scheduled for elective hip or knee replacement at University Hospital
* Mild cognitive impairment, defined as:

* MMSE total score of 27 or less;
* normal performance of the activities of daily living tasks of the Bristol scale after excluding mobility related difficulties;
* no chart-based dementia diagnosis; and
* no history of ever being on dementia medications such as Memantine or any cholinesterase inhibitors
* Consent to participate in the study

Exclusion Criteria

* Chart-based dementia diagnosis
* MMSE score greater than 27
* Difficulty performing the activities of daily living not related to mobility as measured by the Bristol scale
* Current or past history of receiving dementia medications such as Memantine or any cholinesterase inhibitors (Tacrine, Donepezil, Rivastigmine, or Galantamine)
* Metastatic cancer or other comorbid illnesses likely to reduce life expectancy to under 6 months
* Multiple trauma or pathological fractures requiring acute hip or knee replacement
* Aphasic, blind, or deaf
* Use of neuroleptics one month prior to surgery
* Allergy to donepezil
* Inability to read and complete study tests and forms
* Alcohol or drug dependence, defined as intake of more than 5 units of alcohol daily during the past 3 months
* Not expected to be discharged from hospital or able to complete the 3-month postoperative test
* Not competent to make medical decisions

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No